**Core Concept**
Reese-Ellsworth classification is a system used in ophthalmology to categorize the prognosis of patients with retinoblastoma, a malignant tumor of the retina. This classification helps predict the visual potential of the affected eye and guides treatment decisions.

**Why the Correct Answer is Right**
The Reese-Ellsworth classification system divides patients into five groups based on the number and size of tumors within the eye, as well as the presence of vitreous seeds or subretinal seeds. The classification is crucial in determining the suitability of conservative treatments, such as chemotherapy or local therapies, versus enucleation (removal of the eye). The system takes into account the location and extent of the tumor, which affects the visual prognosis.

**Why Each Wrong Option is Incorrect**
**Option A:** Reese-Ellsworth classification is not related to the treatment of diabetic retinopathy.
**Option B:** This classification system does not predict the risk of metastasis in retinoblastoma patients.
**Option C:** Reese-Ellsworth classification is not a system used in the diagnosis of cataracts.

**Clinical Pearl / High-Yield Fact**
It's essential to remember that the Reese-Ellsworth classification is a prognostic tool, not a diagnostic one, and its primary use is in guiding treatment decisions for retinoblastoma patients.

**Correct Answer: D. Retinoblastoma**